Home › High Blood Pressure › NCT06642246
Sleep Promotion and Pediatric Hypertension
Recruiting
Sleep Promotion Among Children Newly Diagnosed With Essential Hypertension
Who can join
Ages 13 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * Speak, read and write in English. * Parental/guardian permission (informed consent) and child assent. * Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan. * Parent reported sleep duration on school nights less than or equal to 7.5 hours. * Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM). * If taking over the counter sleep aides, willing to stop them over the course of the study. Exclusion Criteria: * Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide. * Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes). Inclusion Criteria for Parents/Legal Guardians: * Be the parent/guardian of an eligible child enrolled in the main study. * Speak, read, and write in English. Exclusion Criteria for Parents/Legal Guardians: \- Limited English proficiency
About the study
Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.
What is being tested
- Intervention (behavioral)
Sponsor: Children's Hospital of Philadelphia · Participants: 10 · Started: Feb 16, 2026
Contact the study team
- Jonathan Mitchell · Phone: 267-426-1473
- Abby Salem · Phone: 215-590-2386
Official record on ClinicalTrials.gov — NCT06642246
Locations in the U.S.
| Pennsylvania | Children's Hospital of Philadelphia, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.